First Time Loading...

Immunoprecise Antibodies Ltd
XTSX:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
XTSX:IPA
Watchlist
Price: 6.5 CAD 0.78% Market Closed
Updated: May 6, 2024

Immunoprecise Antibodies Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunoprecise Antibodies Ltd
Cash from Operating Activities Peer Comparison

Comparables:
ABCL
ARCH
RP
IOT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Immunoprecise Antibodies Ltd
XTSX:IPA
Cash from Operating Activities
-CA$600k
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abcellera Biologics Inc
NASDAQ:ABCL
Cash from Operating Activities
-$43.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Cash from Operating Activities
-CA$483.9k
CAGR 3-Years
39%
CAGR 5-Years
25%
CAGR 10-Years
-10%
Replicel Life Sciences Inc
XTSX:RP
Cash from Operating Activities
-CA$2m
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Cash from Operating Activities
-CA$203k
CAGR 3-Years
N/A
CAGR 5-Years
3%
CAGR 10-Years
9%

See Also

What is Immunoprecise Antibodies Ltd's Cash from Operating Activities?
Cash from Operating Activities
-600k CAD

Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Cash from Operating Activities amounts to -600k CAD.

What is Immunoprecise Antibodies Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
44%

Over the last year, the Cash from Operating Activities growth was 57%. The average annual Cash from Operating Activities growth rates for Immunoprecise Antibodies Ltd have been 44% over the past three years .